Hutchmed (China)
HCM
Ermenegildo Zegna NV
ZGN
New Fortress Energy
NFE
Enerpac Tool
EPAC
eBay
EBAY
US Stock MarketDetailed Quotes
GPCR Structure Therapeutics
- 27.060
- +0.080+0.30%
Close Jan 17 16:00 ET
- 27.390
- +0.330+1.22%
Post 20:01 ET
1.55BMarket Cap-14.01P/E (TTM)
27.450High26.500Low846.85KVolume27.150Open26.980Pre Close22.90MTurnover1.56%Turnover RatioLossP/E (Static)57.26MShares62.74052wk High1.73P/B1.47BFloat Cap23.50052wk Low--Dividend TTM54.21MShs Float75.017Historical High--Div YieldTTM3.52%Amplitude20.800Historical Low27.037Avg Price1Lot Size
About Structure Therapeutics Company
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.
Company Profile
SymbolGPCR
Company NameStructure Therapeutics
Listing DateFeb 3, 2023
Issue Price15.00
Founded2019
CEOProfessor Raymond C. Stevens, PhD
MarketNASDAQ
Employees93
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address601 Gateway Boulevard,Suite 900
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-457-1978
Websitehttp://www.structuretx.com
Company Executives
- Name
- Position
- Salary
- Professor Raymond C. Stevens, PhD
- Director and Chief Executive Officer
- --
- Dr. Blai Coll
- Chief Medical Officer
- --
- Dr. Yingli Ma, PhD
- Chief Technology Officer
- --
- Dr. Xichen Lin, PhD
- Chief Scientific Officer
- --
- Ashley F. Hall, J.D.
- Chief Development Officer
- --
- Jun Yoon
- Principal Accounting Officer and Chief Financial Officer
- --
- Daniel G. Welch
- Chairman of the Board
- --
- Eric L. Dobmeier
- Independent Director
- --
- Dr. Ted W. Love, M.D.
- Independent Director
- --
- Dr. Joanne Waldstreicher, M.D.
- Independent Director
- --
- Sharon E. Tetlow
- Independent Director
- --
- Angus Charles Russell
- Independent Director
- --
